drugset / Trial / NCT00943683

Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)

NCT00943683

Completed 256 enrolled Organon and Co
RandomizedParallel-groupDouble-blindTreatment

Summary

A study of Montelukast compared to placebo in asthmatic children aged 6-24 months.

Timeline

Start
2000-08
Primary completion
2001-02
Completion
2001-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 4 mg Oral

Indications